Johnson & Johnson reports record second-quarter sales of $13.4 billion

By Lisa Kerner

Charlotte, N.C., July 18 - For the second quarter of 2006, Johnson & Johnson said it recorded sales of $13.4 billion, a 4.7% increase over the $12.8 billion in sales in the second quarter of 2005.

The company reported adjusted net earnings for the second quarter of $2.9 billion, or $0.98 per diluted share, up from $2.7 billion, or $0.90 per diluted share, during the same period in 2005.

Compared to the prior-year period, second-quarter 2006 worldwide sales of medical devices and diagnostics were up 6.2% at $5.2 billion, pharmaceutical sales were up 3.2% at $5.8 billion and consumer segment sales rose 5.3% to $2.4 billion.

Johnson & Johnson attributed its operational growth in part to the Ethicon Endo-Surgery's minimally invasive products; Cordis' Cypher Sirolimus-eluting Coronary Stent; Vistakon's disposable contact lenses and LifeScan's blood glucose monitoring and insulin delivery products.

Sales growth also reflects the strong performance of Risperdal, Remicade, Topamax, Concerta and McNeil Nutritional's Splenda, as well as the Aveeno and adult skin product lines.

Company highlights for the quarter include acquisition of the medical device company Vascular Control Systems, Inc. and the biotechnology company Colbar LifeScience Ltd.

In addition, the company received CE Mark approval in Europe for the Cypher Select Plus drug-eluting stent and Food and Drug Administration accelerated approval for the anti-HIV medication Prezista.

New Brunswick, N.J.-based Johnson & Johnson is a manufacturer of health care products and provider of related services for the consumer, pharmaceutical, medical devices and diagnostics markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.